Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 2,505 $ 1,461
Accounts receivable 5,649 8,544
Other current assets 1,746 1,768
Total current assets 9,900 11,773
Property and equipment, net 1,423 1,361
Operating lease right of use assets 1,217 1,613
Deferred tax asset 21,254
Other long-term assets 44 45
Total assets 33,838 14,792
Current liabilities:    
Accounts payable 983 1,659
Accrued salary and bonus 1,886 2,207
Other accrued expenses 1,574 1,799
Note payable at fair value, current 4,290
Current liabilities of discontinued operations 660 660
Total current liabilities 5,103 10,615
Operating lease liabilities, net of current portion 752 1,183
Other long-term liabilities 5,620 5,211
Total liabilities 11,475 17,009
Commitments and contingencies (Note 10)
Stockholders’ deficit:    
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series C issued and outstanding, respectively
Common stock, $.01 par value; 100,000,000 shares authorized; 4,569,333 and 4,539,663 shares issued, respectively; 4,428,539 and 4,409,323 shares outstanding, respectively 407 406
Additional paid-in capital 234,833 234,811
Accumulated deficit (210,805) (235,380)
Treasury stock, at cost (140,794 and 130,340 shares, respectively) (2,072) (2,054)
Total stockholders’ equity (deficit) 22,363 (2,217)
Total liabilities and stockholders’ equity (deficit) $ 33,838 $ 14,792